Yang Dongyu, Lu Cihang, Zhang Haonan, Shi Xiaoguang, Sun Ying, Shao Ying, Fan Shuting, Tian Lijun, Teng Di
The Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
The Department of Endocrinology and Metabolism, Institute of Endocrinology, National Health Commission Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Front Endocrinol (Lausanne). 2025 Jul 4;16:1594139. doi: 10.3389/fendo.2025.1594139. eCollection 2025.
Aging is associated with thyroid dysfunction, but the role of phenotypic age, a biological aging measure derived from nine clinical biomarkers and chronological age, remains unclear.
This cross-sectional study included 6,681 adults from the National Health and Nutrition Examination Survey (NHANES, 2007-2012) with complete thyroid function and age data. Participants were grouped into quartiles based on chronological and phenotypic age. Weighted multinomial logistic regression was used to assess the association between aging and thyroid disorders, followed by the use of restricted cubic splines (RCSs) to explore potential nonlinear relationships. Subgroup and sensitivity analyses were conducted to test robustness. Mediation analysis assessed the role of phenotypic age components in the link between phenotypic age and thyroid dysfunction.
Thyroid-stimulating hormone (TSH) and free thyroxine (FT4) exhibited U-shaped relationships with both chronological and phenotypic age, while free triiodothyronine (FT3) showed a nonlinear association with chronological age and a negative linear correlation with phenotypic age. The age gap (phenotypic age minus chronological age) was positively associated with TSH and nonlinearly with FT4. Thyroid peroxidase antibody (TPOAb) exhibits a nonlinear association with both age types, and thyroglobulin antibody (TGAb) has a positive linear association with chronological age. PPhenotypic age showed stronger linear associations with TPOAb positivity (PTPOAb), TGAb positivity (PTGAb), overt hyperthyroidism, and subclinical hypothyroidism than chronological age. Overt hypothyroidism demonstrated an inverted U-shaped association with both age metrics and a positive correlation with age gap. Mediation analysis revealed that mean cell volume mediated 10% of the association between phenotypic age and overt hypothyroidism, while lymphocyte percentage exhibited a negative mediation effect (-26%) in the association between phenotypic age and subclinical hypothyroidism.
Phenotypic age better captures aging-related changes in thyroid function than chronological age and may serve as a useful biological aging marker in clinical endocrine research.
衰老与甲状腺功能障碍相关,但表型年龄(一种由九种临床生物标志物得出的生物衰老指标)和实际年龄在其中的作用仍不明确。
这项横断面研究纳入了来自美国国家健康与营养检查调查(NHANES,2007 - 2012年)的6681名成年人,他们拥有完整的甲状腺功能和年龄数据。参与者根据实际年龄和表型年龄被分为四分位数组。采用加权多项逻辑回归评估衰老与甲状腺疾病之间的关联,随后使用受限立方样条(RCS)来探索潜在的非线性关系。进行亚组分析和敏感性分析以检验稳健性。中介分析评估了表型年龄成分在表型年龄与甲状腺功能障碍之间联系中的作用。
促甲状腺激素(TSH)和游离甲状腺素(FT4)与实际年龄和表型年龄均呈现U形关系,而游离三碘甲状腺原氨酸(FT3)与实际年龄呈非线性关联,与表型年龄呈负线性相关。年龄差距(表型年龄减去实际年龄)与TSH呈正相关,与FT4呈非线性相关。甲状腺过氧化物酶抗体(TPOAb)与两种年龄类型均呈非线性关联,甲状腺球蛋白抗体(TGAb)与实际年龄呈正线性相关。表型年龄与TPOAb阳性(PTPOAb)、TGAb阳性(PTGAb)、显性甲状腺功能亢进和亚临床甲状腺功能减退的线性关联比实际年龄更强。显性甲状腺功能减退与两种年龄指标均呈现倒U形关联,与年龄差距呈正相关。中介分析显示,平均细胞体积介导了表型年龄与显性甲状腺功能减退之间10%的关联,而淋巴细胞百分比在表型年龄与亚临床甲状腺功能减退之间的关联中表现出负中介效应(-26%)。
与实际年龄相比,表型年龄能更好地反映与衰老相关的甲状腺功能变化,并且可能在临床内分泌研究中作为一种有用的生物衰老标志物。